Robeco Schweiz’s AbbVie ABBV Stock Holding History

Robeco Schweiz’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.32M	Hold	21,142	–	–	0.09%	110
2026 Q1	$4.6M	Sell	21,142 -4,370	-17%	-$969K	0.1%	108
2025 Q4	$5.83M	Hold	25,512	–	–	0.13%	113
2025 Q3	$5.91M	Sell	25,512 -7,140	-22%	-$1.45M	0.13%	106
2025 Q2	$6.06M	Sell	32,652 -6,395	-16%	-$1.19M	0.14%	106
2025 Q1	$8.18M	Hold	39,047	–	–	0.2%	96
2024 Q4	$6.94M	Buy	+39,047	New	+$7.18M	0.15%	100

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Robeco Schweiz's ABBV Position: Q2 2026 in Review

Robeco Schweiz held its AbbVie (ABBV) position steady in Q2 2026 at 21,142 shares worth $5.32M. The position accounts for 0.09% of the portfolio, ranked #110.

Robeco Schweiz first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $8.18M in Q1 2025. 4,209 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Robeco Schweiz held 21,142 shares of AbbVie worth $5.32M as of Q2 2026.
Robeco Schweiz left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.09% of Robeco Schweiz's portfolio in Q2 2026, its #110 holding.
Robeco Schweiz first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
Robeco Schweiz's AbbVie position peaked at $8.18M in Q1 2025.
4,209 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Robeco Schweiz's 13F filing for Q2 2026, filed 28 Jul 2026.